// App-Quantinova.ai

198 : Heterogeneity of prostate-specific membrane antigen (PSMA) expression in classic and apoptotic circulating tumor cells (CTC) in metastatic castration-resistant prostate cancer (mCRPC).

Researchers

Presenter

  • Karen A. Autio

Principal Investigators

  • Aseem Anand

  • Rachel Krupa

  • Jessica Louw

  • Zaina Arslan

  • Ryan Dittamore

  • Howard I. Scher

Medical Centers

  • Memorial Sloan Kettering Cancer Center, Port Washington, NY

  • Epic Sciences, Inc., La Jolla, CA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Metastatic castration-resistant prostate cancer

Biomarkers

  • Circulating tumor cells

  • Cluster of differentiation 45

  • Folate Hydrolase 1

Drug/Treatment

  • Alkaline phosphatase

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved